Desflurane Inhalation
PreclinicalSmall molecule
Desflurane Inhalation is one of 6 small molecule programs targeting Postoperative Sleep Quality. It is currently in Preclinical.
2
Indications
3
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Post Operative Cognitive Dysfunction
#DrugCompanyPhaseTrials
1Dexmedetomidine Hydrochloride
PfizerPhase 3
Gocovri
GGrupo Espanol de Tumores Neuroendocrinos
Preclinical
Desflurane Inhalation
XXiaguang Duan
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Postoperative Sleep Quality1 trial
Post Operative Cognitive Dysfunction1 trial
Remifentanil1 trial
Desflurane and Sevoflurane on Remifentanil Requirement
Unknown status·—·N/A·NCT06123624·78 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Desflurane Inhalation. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- XXiaguang Duan